| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.22 | 9e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |